Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2021 June Clinical trials Addition of lenalidomide to r-chop improves outcomes in newly diagnosed diffuse large B-cell l... Read more
2021 June Clinical trials Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adu... Read more
2021 May Clinical practice Copanlisib plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma Read more
2020 August Clinical trials The GRIFFIN study: daratumumab-RVd in transplant-eligible newly-diagnosed multiple myeloma Read more
2020 August Clinical trials ASPIRE extension study: recombinant factor VIII Fc fusion protein in treatment of severe haemo... Read more
Top
